Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Protective Efficacy of BCG Vaccination Against Controlled Human Malaria Infection
NCT02692963Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2016
- Primary completion
- Oct 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of bcg vaccine in malaria, sponsored by Radboud University Medical Center. Started Apr 2016; status: completed.
02
Drugs
bcg vaccine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02692963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02692963.